Použitá literatúra

  1. Řehák, J., Rehák, M., a kol.: Venózní okluze sítnice. Grada, 2011.
  2. Klein, R., Klein, B. E., Moss, S. E., et al.: The epidemiology of retinal vein occlusion: the Beaver Dam Eye Study. Trans. Am. Ophtalmol. Soc. 2000, 98: 133 – 141.
  3. Rath, E. Z., Frank, R. N., Shin, D. H. et al.: Risk factors for retinal vein occlusions. A case control study. Ophtalmology, 1992, 99 p. 509 – 514.
  4. Rogers, S. L., McIntosh, R. L., Lim, L. et al.: Natural History of Branch Retinal Vein Occlusion: An Evidence-Based Systematic Review. Ophtalmology,2010, Apr 27.
  5. O´Mahoney, P. R., Wong, D. T., Ray, J. G. Retinal vein occlusion and traditional risk factors for atherosclerosis. Arch. Ophtalmol., 2008, 126, p. 692 – 699.
  6. Yau, J. W., Lee, P., Wong, T. Y., Best, J. et al.: Retinal vein occlusion: an approach to diagnosis, systemic risk factors and management. Intern Med J, 2008,38: 904 – 910.
  7. Branch Vein Occlusion Study Group: Argon laser scatter photocoagulation for prevention of neovascularisation and vitreous haemorhage in branch retinal vein occlusion. Arch. Ophtalmol., 1986,104, p. 34 – 41.
  8. Central Vein Occlusion Study Group. Natural History and Clinical Management of Central Retinal Vein Occlusion. Arch. Ophtalmol., 1997, 115, p. 486 – 491.
  9. Guttman, F. A., Zegarra, H., Zakov, Z. N. The natural course of temporal retinal vein occlusion. Trans. Am. Acad. Ophtalmol. Otolaryngol.1974, 78, p. 178 – 192.
  10. Guttman, F. A. Macular edema in branch retinal vein occlusion: prognosis and management. Trans. Am. Acad. Ophtalmol. Otolaryngol.1977, 83, p. 488 – 493.
  11. Campochiaro, P. A., Heier, J. S., Feiner, L., Gray, S. et al.: Ranibizumab for Macular Edema following Branch Retinal Vein Occlusion six-months Primary end Point Resuslts of Phase III Study. Ophtalmology, 2010, 14.
  12. Spaide, R. F., Chang, L. K., Klancnik, J. M. et al.: Prospective study of intravitreal ranibizumab as a treatment for decreased visual acuity secondary to central retinal vein occlusion. Am J Ophtalmol, 2009, 147: 298 – 306.
  13.  13: Hoerauf, H., Feltgen, N., Weiss, C. et al.: Clinical Efficacy and Safety of Ranibizumab Versus Dexamethasone for Central Retinal Vein Occlusion (COMRADE C): A European Label Study. Am J Ophtalmol, 2016, Sep. 169: 258 – 267.
  14. Haller, J. A., Bandello, F., Belfort, R., Blumenkraz, M. S. et al.: (OZURDEX GENEVA Study Group): Randomized, Sham-controlled Trial of Dexamethasone Intravitreal Implant in Patients with Macular Edema Due to Retinal Vein Occlusion. Ophtalmology, 2010., 117: 1134 – 1146.

SK1904669167